designated HVTN

Related by string. * desig nated . Designating . designating . DESIGNATED . Designated : designated hitter Jim Thome . designated hitter Travis Hafner . designated hitter Jason Giambi . designated hitter Vladimir Guerrero . designated hitter Jorge Posada . designated hitter Hideki Matsui . designated hitter Aubrey Huff . designated Argus Observer / : HVTN . Network HVTN . HVTN funded * *

Related by context. Frequent words. (Click for all words.) 65 HVTN 64 Network HVTN 63 blinded placebo controlled 63 Phase Ib clinical 63 phase IIb clinical 62 Phase 1b clinical 62 PREZISTA r 62 multicenter clinical 61 Traficet EN 61 phase IIa 61 Randomized controlled 61 Initiate Phase 61 Phase IIIb 61 transcriptase inhibitor NNRTI 61 phase Ib 61 patients undergoing percutaneous 61 Phase Ib II 60 active comparator 60 Phase Ia 60 forodesine 60 relapsed refractory multiple myeloma 60 phase IIa clinical 60 refractory chronic lymphocytic 60 APTIVUS 60 placebo controlled Phase 60 multicenter randomized 60 liposomal formulation 59 Esoterix Clinical Trials 59 multicenter Phase 59 Brentuximab vedotin 59 double blinded placebo 59 PRECiSE 59 randomized Phase III 59 polymerase inhibitor 59 randomized multicenter 59 prospective multicenter 59 label multicenter 59 multicentre 59 http:/www.clinicaltrials.gov 59 SAR# [004] 59 Phase III Clinical Trial 59 multiple ascending dose 58 Alzheimer Disease Cooperative 58 SCH # 58 Pegasys ® 58 CALGB 58 TYGACIL 58 HBsAg 58 dose escalation trial 58 chronic HCV infection 58 Phase 2a trial 58 Phase 2b clinical trials 58 Investigational Device Exemption 58 hepatitis C HCV 58 Sym# 58 OncoVEX GM CSF 58 tanespimycin 58 Pivotal Phase 58 Cetrorelix 58 Daclizumab 58 placebo controlled clinical 57 TELCYTA 57 pre exposure prophylaxis 57 Belimumab 57 Pivotal Phase III 57 multicenter randomized double 57 Phase 1b trial 57 CAPRISA 57 rilonacept 57 ZOSTAVAX 57 prospective observational 57 Thrombolysis 57 Phase 1a 57 Telmisartan 57 StemEx 57 pharmacokinetics PK 57 tigecycline 57 randomized #:# 57 II Clinical Trial 57 PROPEL trial 57 Multicenter 57 nonrandomized 57 DNA RNA Medicines 57 Gemzar ® 57 Phase 2a clinical 57 sodium Injection 57 NCT# 57 phase IIb 57 relapsing multiple sclerosis 57 nab paclitaxel 56 6R BH4 56 Diamyd R 56 Phase IIB 56 Gynecologic Oncology Group 56 Natural Catastrophe Stress 56 ferric citrate 56 MORAb 56 Ofatumumab 56 lanthanum carbonate 56 Diabetic Macular Edema 56 RiVax ™

Back to home page